Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Angeliq for Vasomotor Symptoms in Korean Postmenopausal Women
NCT00651599Phase 3Completed
- Sponsor
- Bayer
- Start
- Jul 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of estradiol + drospirenone in vasomotor symptoms, menopause, sponsored by Bayer. Started Jul 2004; status: completed.
02
Drugs
estradiol + drospirenone
03
Conditions
vasomotor symptomsmenopause
Beyond the preview
Go deeper on NCT00651599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00651599.